Guillermo Rosa-Diez, María Marina Papaginovic Leiva, Fernando Lombi, María Soledad Crucelegui, Ricardo D Martínez, Hernán Trimarchi, Rubén Schiavelli, Mercedes Grizzo, Miguel Raño, Ricardo M Heguilén, Rocío A Jones, Luciana González Paganti, Matías Ferrrari, Victoria Kjohede, Paula Zingoni, Jorge R Geffner, Daniel Ferrante, Fernán González Bernaldo De Quirós, Vanina Pagotto
INTRODUCTION: Given the vulnerability of chronic kidney disease individuals to SARS-CoV-2, nephrology societies have issued statements calling for prioritization of these patients for vaccination. It is not yet known whether COVID-19 vaccines grant the same high level of protection in patients with kidney disease compared to the non-dialysis population. The aims of this study were to evaluate the safety - measured by the adverse events potentially attributed to vaccines (ESAVI) - and the effectiveness - evaluated by the presence of antibodies - in dialysis patients immunized with the COVID-19 Sputnik V vaccine...
2022: Medicina